Table 2.
β1Ser49Gly | β1Arg389Gly | Controls | Patients with heart failure | Odds ratio for heart failure (95%CI) | P-value |
---|---|---|---|---|---|
No. of subjects | |||||
119 | 91 | ||||
≧ 1Gly | ≧ 1Gly | 6 | 6 | 1.00 | – |
≧ 1Gly | Arg/Arg | 30 | 19 | 0.63 (0.18–2.25) | 0.35 |
Ser/Ser | ≧ 1Gly | 34 | 25 | 0.74 (0.21–2.55) | 0.43 |
Ser/Ser | Arg/Arg | 49 | 41 | 0.84 (0.25–2.79) | 0.50 |
Subjects with at least one β1Gly49 allele and at least one β1Gly389 allele served as the reference group. Odds ratios and P-values between the reference group and each other group were determined by 2 ×2 χ2 test. P-value < 0.017 (0.05/3) was considered to be significant.